2'-hydroxyflavanone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awasthi, S; Chikara, S; Gugiu, G; Horne, D; Nagaprashantha, LD; Salgia, R; Singhal, J; Singhal, SS | 1 |
1 other study(ies) available for 2'-hydroxyflavanone and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells.
Topics: Antineoplastic Agents; Female; Flavanones; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Neoplasm Metastasis; Neoplasm Proteins; Proteome; Proteomics; Transcriptome; Triple Negative Breast Neoplasms | 2019 |